Download PDF
Horm Metab Res 2020; 52(01): 49-57
DOI: 10.1055/a-1073-2346
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

Dynamic Analysis of the Biochemical Changes in Rats with Polycystic Ovary Syndrome (PCOS) Using Urinary 1H NMR-Based Metabonomics

Wei Huang‡
,
Shanxia Li‡
,
Naxin Luo‡
,
Kena Lu
1   Gynaecology, The First Affiliated Hospital, Guangxi Traditional Chinese Medicine University, Nanning 530023, China
,
Sheng Ban
1   Gynaecology, The First Affiliated Hospital, Guangxi Traditional Chinese Medicine University, Nanning 530023, China
,
Hanmei Lin
1   Gynaecology, The First Affiliated Hospital, Guangxi Traditional Chinese Medicine University, Nanning 530023, China
› Author Affiliations Funding Information: National Natural Science Foundation of China, Grant No. 81360555.
Further Information

Publication History

received 23 September 2019

accepted 27 November 2019

Publication Date:
16 January 2020 (online)

Also available at
    Permissions and Reprints

Abstract

Polycystic ovarian syndrome (PCOS) is the most common endocrine disease that causes reproductive abnormalities in fertile women. It is closely related to the persistent anovulatory, insulin resistance, and high androgen. However, the molecular mechanisms underlying the pathological development of PCOS are still unclear. In this study, we aimed to explore the distinctive metabolic patterns in insulin combined with human chorionic gonadotrophin induced PCOS. The dynamic changes of endogenous metabolites in the development of PCOS were studied using untargeted metabolomic approaches based on nuclear magnetic resonance. The results showed that the degree of PCOS disorder metabolites at different periods was not exactly the same. Twelve significantly differential endogenous metabolites from different time points were selected as potential biomarkers relate to pathological process of PCOS. Among them, six metabolites showed a good diagnostic accuracy with PCOS model. The arginine and proline metabolic pathway was considered as one of the most crucial pathways that affects occurrence and development of PCOS. In addition, IRS-1, Akt, PI3K, IκB, and NF-κB (p65) were significantly changed in the ovary tissue of PCOS rats, which revealed that the IRS-1-PI3K/Akt and NF-κB signal pathway may be involved in the development of PCOS. This study demonstrated that metabolomic analysis is a powerful tool for providing novel insight into understanding the pathogenesis of PCOS and provide a basic reference for the diagnosis of PCOS at the onset stage.

Key words

metabonomics - dynamic analysis - polycystic ovary syndrome - nuclear magnetic resonance
 

  • References

  • 1 Wei Z, Cao Y, Cong L. et al. Retraction notice to Effect of metformin pretreatment on pregnancy outcome of in vitro matured oocytes retrieved from women with polycystic ovary syndrome. Fertil Steril 2015; 104: 1048-1048
    CrossrefPubMedGoogle Scholar
  • 2 Azziz R, Woods KS, Reyna R. et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89: 2745-2749
    CrossrefPubMedGoogle Scholar
  • 3 Himelein MJ, Thatcher SS. Polycystic ovary syndrome and mental health: A review. Obstetr Gynecol Surv 2006; 61: 723
    CrossrefPubMedGoogle Scholar
  • 4 Azziz R, Carmina E, Dewailly D. et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab 2006; 91: 4237-4245
    CrossrefPubMedGoogle Scholar
  • 5 Zhang Y, Liu L, Yin TL. et al. Follicular metabolic changes and effects on oocyte quality in polycystic ovary syndrome patients. Oncotarget 2017; 8: 80472-80480
    CrossrefPubMedGoogle Scholar
  • 6 Steinberg HO, Brechtel G, Johnson A. et al. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172-1179
    CrossrefPubMedGoogle Scholar
  • 7 Artunc F, Schleicher E, Weigert C. et al. The impact of insulin resistance on the kidney and vasculature. Nat Rev Nephrol 2016; 12: 721-737
    CrossrefPubMedGoogle Scholar
  • 8 Liu M, Gao J, Zhang Y. et al. Serum levels of TSP-1, NF-κB and TGF-β1 in polycystic ovarian syndrome (PCOS) patients in northern China suggest PCOS is associated with chronic inflammation. Clin Endocrinol 2016; 83: 913-922
    PubMedGoogle Scholar
  • 9 Coen M, Holmes E, Lindon JC. et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2007; 21: 9
    PubMedGoogle Scholar
  • 10 Tian JS, Peng GJ, Gao XX. et al. Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoyaosan using urinary (1)H NMR-based metabolomics. J Ethnopharmacol 2014; 158: 1-10
    CrossrefPubMedGoogle Scholar
  • 11 Jiang L, Huang J, Wang Y. et al. Eliminating the dication-induced intersample chemical-shift variations for NMR-based biofluid metabonomic analysis. Analyst 2012; 137: 4209-4219
    CrossrefPubMedGoogle Scholar
  • 12 Ghosh S, Sengupta A, Sharma S. et al. Metabolic fingerprints of serum, brain, and liver are distinct for mice with cerebral and noncerebral malaria: A 1H NMR spectroscopy-based metabonomic study. J Proteome Res 2012; 11: 4992
    CrossrefPubMedGoogle Scholar
  • 13 Zhou YZ, Yan ML, Gao L. et al. Metabonomics approach to assessing the metabolism variation and gender gap of Drosophila melanogaster in aging process. Exp Gerontol 2017; 98: 110-119
    CrossrefPubMedGoogle Scholar
  • 14 Fornes R, Ormazabal P, Rosas C. et al. Changes in the expression of insulin signaling pathway molecules in endometria from polycystic ovary syndrome women with or without hyperinsulinemia. Molecular Medicine 2010; 16: 129
    PubMedGoogle Scholar
  • 15 Wang FF, Pan JX. Hyperandrogenism Involved in Pathogenesis of Polycystic Ovary Syndrome. J Int Reprod Health/Family Planning. 2013; http://jfprhc.bmj.com/
    PubMed
  • 16 Moran L, Teede H. Metabolic features of the reproductive phenotypes of polycystic ovary syndrome. Hum Reprod Update 2009; 15: 477-488
    CrossrefPubMedGoogle Scholar
  • 17 Livingstone C, Collison M. Sex steroids and insulin resistance. Clinical Science 2002; 102: 151-166
    CrossrefPubMedGoogle Scholar
  • 18 Ridker PM, Hennekens CH, Roitmanjohnson B. et al. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 1998; 351: 88-92
    CrossrefPubMedGoogle Scholar
  • 19 Yang Z, Zheng Q, Shi Y. Correlation of C-reactive protein with carotid intima-media wall thickness and flow nediated dilatation in women with polycystic ovary syndrome. J Pract Obstetr Gynecol. 2009; 25(08): 468-471
    PubMedGoogle Scholar
  • 20 Tong BC, Barbul A. Cellular and physiological effects of arginine. Mini Rev Med Chem 2004; 4: 823-832
    CrossrefPubMedGoogle Scholar
  • 21 Zhao Y, Fu L, Li R. et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 2012; 10: 153
    CrossrefPubMedGoogle Scholar
  • 22 Zhang ZS, Dong S, Gao YF. et al. Effect of inositol and D-chiro-inositol on alcoholic fatty liver rats. China Food Additiv. 2014; (09): 85-90
    PubMedGoogle Scholar
  • 23 Ahn CW, Kwon DY, Jun DS. et al. Enhancement of cysteine catabolism into taurine impacts glutathione homeostasis in rats challenged with ethanol. Amino Acids 2015; 47: 1273-1277
    CrossrefPubMedGoogle Scholar
  • 24 Achreja A. Metabolic shifts toward glutamine regulate tumor growth and invasion in ovarian cancer. Fertil Steril 2014; 728-728
    PubMedGoogle Scholar
  • 25 Møller N, Meek S, Bigelow M. et al. The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: A metabolic role of the kidney. Proc Natl Acad Sci U S A 2000; 97: 1242
    CrossrefPubMedGoogle Scholar
  • 26 Diamanti-Kandarakis E, Alexandraki K, Piperi C. et al. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 2006; 36: 691-697
    CrossrefPubMedGoogle Scholar
  • 27 Koppenol WH, Bounds PL, Dang CV. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat Rev Cancer 2011; 11: 325-337
    CrossrefPubMedGoogle Scholar
  • 28 Lin XF, Ri-Ran WU, Jing DU. et al. Value of free androgen index for diagnosis of hyperandrogenism in polycystic ovary syndrome. J Sun Yat-Sen Univ (Medical Sciences) 2010; 31: 391-396
    PubMedGoogle Scholar
  • 29 Anna Miczke JS, Danuta P-M, Lucyna O. et al. Effect of L-arginine supplementation on insulin resistance and serum adiponectin concentration in rats with fat diet. Int J Clin Exp Med 2015; 8: 10358
    PubMedGoogle Scholar
  • 30 Proctor SD, Kelly SE, Russell JC. A novel complex of arginine–silicate improves micro- and macrovascular function and inhibits glomerular sclerosis in insulin-resistant JCR:LA-cp rats. Diabetologia 2005; 48: 1925-1932
    CrossrefPubMedGoogle Scholar
  • 31 Pappalardo MA, Vita R, Di Bari F. et al. Gly972Arg of IRS-1 and Lys121Gln of PC-1 polymorphisms act in opposite way in polycystic ovary syndrome. J Endocrinol Invest 2017; 40: 367-376
    CrossrefPubMedGoogle Scholar
  • 32 Giandalia A, Pappalardo MA, Russo GT. et al. Influence of peroxisome proliferator-activated receptor-gamma exon 2 and exon 6 and insulin receptor substrate (IRS)-1 Gly972Arg polymorphisms on insulin resistance and beta-cell function in southern mediterranean women with polycystic ovary syndrome. J Clin Transl Endocrinol 2018; 13: 1-8
    PubMedGoogle Scholar